Ventriculostomy-Associated Infection (VAI): In Search of a Definition
- 352 Downloads
We read with great interest the article by Gozal et al. on ventriculostomy-associated infection (VAI) . The authors propose that a standardized definition for VAI should be a CSF microbiological culture that is positive for microorganism and associated with fever or low CSF glucose. While the authors should be commended on their attempt to define VAI with unifying nomenclature and classification in the literature, there is a problem regarding neuroICU patients with ventriculostomy and neurogenic fever: Prone patients such as subarachnoid hemorrhage (SAH) and/or intraventricular hemorrhage (IVH) patients with ventricular catheters who have a CSF microbial contaminant that is not found on repeat CSF testing should be excluded from this definition. The other nosocomial organisms that the authors report, such as MRSA and Pseudomonas, are rarely contaminants, similar to Candida and various fungal species.
Further, SAH/IVH patients may develop a sterile inflammatory response that causes...
- 2.Fishman RA. Cerebrospinal fluid in diseases of the nervous system. 2nd ed. Philadelphia: W. B. Saunders Company; 1992.Google Scholar
- 4.Joint Commission, Comprehensive Stroke Center Pre-Publication Guidelines. http://www.jointcommission.org/certification/advanced_certification_comprehensive_stroke_centers.aspx. Accessed 1 July 2014.
- 6.Teufack SG, Campbell P, Jabbour P, Maltenfort M, Evans J, Ratliff JK. Potential financial impact of restriction in “never event” and periprocedural hospital-acquired condition reimbursement at a tertiary neurosurgical center: a single-institution prospective study. J Neurosurg. 2010;112:249–56.CrossRefGoogle Scholar
- 10.Hanley D, Johns Hopkins University, National Institute of Neurological Disorders and Stroke, Genentech, Emissary International LLC. Clot Lysis: evaluating accelerated resolution of intraventricular hemorrhage phase III (CLEAR III trial). In: ClinicalTrials.gov [Internet]. Bethesda, (MD): National Library of Medicine (US). 2014. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00784134?term=clear+ivh&rank=2NLMIdentifier:NCT00784134. Accessed 21 July 2014.
- 11.Ziai W, McBee N, Butcher K, et al. Safety endpoints and thromboembolic events for the first 250 patients enrolled in the Clot Lysis: evaluation of accelerated resolution of intraventricular hemorrhage trial (CLEAR III). Presented at the 2014 International Stroke Conference (ISC), American Heart Association, San Diego. Available at: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_460338.pdf. Accessed 22 July 2014.